An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy

PURPOSE: Fosaprepitant is an antiemetic used for chemotherapy-induced nausea and vomiting. We recently reported increased infusion site adverse events (ISAE) in a cohort of breast cancer patients receiving chemotherapy with doxorubicin and cyclophosphamide (AC). In this current study, we evaluated t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Support Care Cancer
Main Authors: Hegerova, Livia T., Leal, Alexis D., Grendahl, Darryl C., Seisler, Drew K., Sorgatz, Kristine M., Anderson, Kari J., Hilger, Crystal R., Loprinzi, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4383176/
https://ncbi.nlm.nih.gov/pubmed/24964876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-014-2326-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados